Free equity investment tool of Japanese companies

HOME >
Company List >
Daito Pharmaceutical Co . (Second quarter ): Financial Outline Report

Financial Outline Report: Annual; First quarter; Second quarter; Third quarter

Sponsored Link

Related Company: 扶桑化学工業; KUREHA; DAINICHISEIKA COLOR & CHEMICALS MFG.; EBARA-UDYLITE　; TIGERS POLYMER; Daito Pharmaceutical Co .; Fukuvi Chemical Industry; HAGIHARA INDUSTRIES; Ube Industries; MUTO SEIKO CO.; OSAKA ORGANIC CHEMICAL INDUSTRY; TEIJIN　; Maruo Calcium; Soda Aromatic; 堺化学工業

EDIUNET Related Ranking: EDIUNET; EDIUNET Credit Rating; EDIUNET Industry Avg; EDIUNET Prefectures; Yuho! Industry

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

RSS

Company RSS

Daily RSS

Sponsored Link

Recently Download Chart: メルコホールディングス

Nissan Motor

Nittetsu Mining

Hitachi Zosen etc.

KIKUSUI ELECTRONICS etc.

Financial Outline Report: Daito Pharmaceutical Co . (Second quarter )

It is a free Financial Outline Report which can grasp intuitively a financial statement summary , a corporate value, credit rating, etc. by various charts.Two or more companies can be compared and various charts can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Summary: Daito Pharmaceutical Co . (Second quarter )

Credit Rating (Bankruptcy Risk) Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-11-30	AA	Credit is very high, slightly affected by biz environs.	¥ 15 B 4.94%	¥ 1 B 12.24%	¥ 911 M 0.10%

Financial Timeline

Date	2013-02-28 (Third quarter )	2013-05-31 (Annual )	2013-08-31 (First quarter )	2013-11-30 (Second quarter )
Credit Rating	AA	AA	A	AA
Total Assets	¥ 34 B	¥ 34 B	¥ 35 B	¥ 36 B
Net Assets	¥ 14 B	¥ 15 B	¥ 15 B	¥ 15 B

Net sales and net income has increased 4 consecutive terms, and, because of positive operating cash flow. The performance is good.

Net Assets have increased 4consecutive terms. The fiscal base is getting better.

Financial Chart Download

Financial Timeline Chart

Financial Statement Details

Indicator Comparison Chart *It is possible to change a chart.

Financial Indicator Details

Profitability	2010-11-30	2011-11-30	2012-11-30	2013-11-30
Net profit margin (Industry Average)	4.22% (-0.40%)	6.31% (-1.38%)	6.22% (-1.48%)	5.93% (-4.89%)
C/F margin (Industry Average)	7.33% (7.18%)	11.15% (5.00%)	5.32% (-0.56%)	8.00% (-6.57%)
ROA (Industry Average)	1.81% (1.33%)	2.86% (1.83%)	2.75% (1.12%)	2.52% (1.10%)
ROE (Industry Average)	5.20% (1.04%)	7.94% (2.67%)	7.26% (4.56%)	5.77% (4.45%)
Growth	2010-11-30	2011-11-30	2012-11-30	2013-11-30
Equity growth (Industry Average)	- (2.77%)	10.02% (3.14%)	14.28% (0.92%)	26.03% (5.86%)
Sales growth (Industry Average)	- (-)	12.28% (6.71%)	6.17% (1.48%)	4.94% (1.53%)
Net profit growth (Industry Average)	- (162.66%)	67.91% (269.46%)	4.55% (-97.31%)	0.10% (-0.90%)
Operating C/F growth (Industry Average)	- (64.03%)	70.82% (79.67%)	-49.27% (91.34%)	57.56% (69.25%)
Stability	2010-11-30	2011-11-30	2012-11-30	2013-11-30
Capital adequacy (Industry Average)	34.85% (55.14%)	36.06% (55.64%)	37.96% (55.09%)	43.68% (58.36%)
Liquidity ratio (Industry Average)	111.89% (231.67%)	114.58% (243.70%)	117.51% (230.61%)	132.49% (250.24%)
C/F ratio current liabilities (Industry Average)	1,314.26% (764.40%)	838.79% (311.67%)	1,826.22% (101.18%)	1,205.47% (69.39%)
Quick ratio (Industry Average)	78.81% (154.19%)	81.72% (153.27%)	86.82% (153.48%)	83.11% (163.56%)
Turnover	2010-11-30	2011-11-30	2012-11-30	2013-11-30
Receivables turnover (Industry Average)	228.12day (135.50day)	222.27day (132.27day)	243.40day (131.68day)	226.23day (185.68day)
Inventory turnover (Industry Average)	100.83day (75.83day)	93.65day (73.54day)	92.58day (244.57day)	118.38day (80.71day)
Payable turnover (Industry Average)	92.00day (73.12day)	79.74day (71.42day)	81.47day (70.50day)	91.28day (67.06day)
Working capita turnover (Industry Average)	236.95day (138.22day)	236.18day (205.27day)	254.51day (141.93day)	253.32day (145.69day)
Stock etc.	2010-11-30	2011-11-30	2012-11-30	2013-11-30
Market Value growth (Industry Average)	- (-0.06%)	41.09% (1.59%)	24.81% (-6.87%)	12.63% (14.46%)
Dividend Yield (Industry Average)	2.57% (2.02%)	1.83% (0.41%)	2.20% (0.53%)	2.14% (0.42%)
PER (Industry Average)	13.37% (-30.47%)	11.23% (293.36%)	13.41% (19.58%)	15.09% (24.48%)
PBR (Industry Average)	0.69% (0.98%)	0.89% (0.99%)	0.97% (0.91%)	0.87% (1.00%)
PCFR (Industry Average)	7.70% (14.06%)	6.36% (2.01%)	15.65% (2.36%)	11.19% (-30.87%)
PSR (Industry Average)	0.56% (1.51%)	0.70% (1.23%)	0.83% (3.27%)	0.89% (1.82%)

Corporate value chart

Enterprise Value	2010-11-30	2011-11-30	2012-11-30	2013-11-30
Market Value	¥ 6 B (1)	¥ 9 B (1)	¥ 12 B (1)	¥ 13 B (1)
Net Value	¥ 9 B (0.7)	¥ 10 B (0.89)	¥ 12 B (0.97)	¥ 15 B (0.87)
Returns Value	¥ 7 B (0.93)	¥ 10 B (0.9)	¥ 10 B (1.14)	¥ 13 B (1.01)
Dividend Value	¥ 2 B (2.7)	¥ 2 B (4.37)	¥ 3 B (3.85)	¥ 4 B (3.11)
Enterprise Value	¥ 15 B (0.46)	¥ 18 B (0.53)	¥ 21 B (0.56)	¥ 21 B (0.64)

Related Information: Daito Pharmaceutical Co . (Second quarter )

Statement Type: Annual : Daito Pharmaceutical Co .; First quarter : Daito Pharmaceutical Co .; Second quarter : Daito Pharmaceutical Co .; Third quarter : Daito Pharmaceutical Co .

Analysis Menu: Outline : Daito Pharmaceutical Co .; Statement : Daito Pharmaceutical Co .; Rating : Daito Pharmaceutical Co .; Indicator : Daito Pharmaceutical Co .; Download : Daito Pharmaceutical Co .

Industry Comparison Ranking: Chemicals - EDIUNET Industry Rankings; Chemicals - EDIUNET Credit Rating; Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company: Toyama - EDIUNET Prefectures; Toyama富山市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals): 1/23 Chemicals (Milbon:AA→AAA); 1/17 Chemicals (Kawaguchi Chemica..; 1/15 Chemicals (HOKKO CHEMICAL IN..; 1/10 Chemicals (OSAKA ORGANIC CHE..; 1/9 Chemicals (SANKO GOSEI:A); 12/27 Chemicals (Niitaka:A); 12/18 Chemicals (KUMIAI CHEMICAL I..; 12/12 Chemicals (IHARA CHEMICAL IN..; 12/11 Chemicals (Konoshima Chemica..; 12/10 Chemicals (NATOCO:AA)

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

HOME >
Company List >
Daito Pharmaceutical Co . (Second quarter ): Financial Outline Report

EDIUNET Rating News

Screening Search

Member limited service

Company Search
- [close]
  
  [keyword]
  
  Company Search
  
  *It can search to each item of a type of industry, a stock market, the settlement-of-accounts moon, and a keyword.
  
  *Top 30 search results are displayed.
  
  [close]

Company Ranking